Medicare Enrolled
Dr. Samuel Koszer, MD
Neurology · Poughkeepsie, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Koszer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Koszer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Koszer
Dr. Samuel Koszer is a neurology specialist in Poughkeepsie, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Koszer performed 2,344 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Koszer received a total of $21,180 from 43 pharmaceutical and/or device companies across 286 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Koszer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 18% volume in NY
$21,180 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,344
Medicare services
Top 18% in NY for neurology
Not available
Unique patients (not deduplicated)
$110
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
872 | $93 | $285 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
352 | $83 | $228 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
214 | $173 | $475 |
| VEEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
146 | $156 | $457 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
131 | $120 | $371 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
111 | $42 | $83 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
96 | $146 | $418 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
78 | $110 | $295 |
| EEG monitoring, 12-26 hours This procedure involves monitoring brain wave activity using an electroencephalogram (EEG) for a duration of 12 to 26 hours. |
71 | $140 | $609 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
69 | $175 | $501 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
47 | $67 | $156 |
| Continuous EEG brain wave monitoring A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously. |
38 | $180 | $387 |
| Video EEG monitoring, 2-12 hours This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report. |
22 | $101 | $299 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
22 | $147 | $433 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
20 | $100 | $318 |
| EEG monitoring, 37-60 hours with review This procedure involves monitoring brain wave activity for 37 to 60 hours. A healthcare professional reviews the data and provides a report. |
17 | $175 | $464 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
14 | $30 | $76 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $56 | $202 |
| New patient office visit, complex (60-74 min) | 11 | $154 | $489 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$21,180
Total received (2018-2024)
Avg $3,026/year across 7 years
Top 18% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
286
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,843
2023
$1,277
2022
$1,316
2021
$294
2020
$203
2019
$9,436
2018
$6,810
Payments by company (2024)
Neurocrine Biosciences, Inc.
$533
ABBVIE INC.
$267
UCB, Inc.
$160
Harmony Biosciences Llc
$119
ARGENX US, INC.
$95
Eisai Inc.
$87
PFIZER INC.
$86
Teva Pharmaceuticals USA, Inc.
$72
EMD Serono, Inc.
$64
Neurelis, Inc.
$61
Takeda Pharmaceuticals U.S.A., Inc.
$58
Genentech USA, Inc.
$44
Grifols USA, LLC
$37
Alexion Pharmaceuticals, Inc.
$30
Axsome Therapeutics, Inc.
$25
Lilly USA, LLC
$25
Biogen, Inc.
$23
Octapharma USA, Inc.
$23
HARMONY BIOSCIENCES LLC
$18
Amgen Inc.
$16
Top 3 companies account for 52.1% of 2024 payments
All-time payments by company (2018-2024) ›
EMD Serono, Inc.
$16,231
Neurocrine Biosciences, Inc.
$892
ABBVIE INC.
$865
Teva Pharmaceuticals USA, Inc.
$319
Genentech USA, Inc.
$238
UCB, Inc.
$237
Neurelis, Inc.
$178
ARGENX US, INC.
$155
PFIZER INC.
$147
Biogen, Inc.
$139
Janssen Pharmaceuticals, Inc
$126
Harmony Biosciences Llc
$119
LivaNova USA, Inc.
$108
Amgen Inc.
$105
GENZYME CORPORATION
$101
JAZZ PHARMACEUTICALS INC.
$99
Monteris Medical Corporation
$92
Eisai Inc.
$87
Harmony Biosciences LLC
$84
Takeda Pharmaceuticals U.S.A., Inc.
$79
Alexion Pharmaceuticals, Inc.
$76
AbbVie Inc.
$74
Sunovion Pharmaceuticals Inc.
$70
Novartis Pharmaceuticals Corporation
$62
TG THERAPEUTICS, INC.
$47
HARMONY BIOSCIENCES LLC
$38
Jazz Pharmaceuticals Inc.
$38
Grifols USA, LLC
$37
Alnylam Pharmaceuticals Inc.
$35
IDORSIA PHARMACEUTICALS US INC
$31
Lundbeck LLC
$27
Medtronic USA, Inc.
$26
Axsome Therapeutics, Inc.
$25
Lilly USA, LLC
$25
IMPEL PHARMACEUTICALS INC.
$24
Octapharma USA, Inc.
$23
Genentech, Inc.
$21
E.R. Squibb & Sons, L.L.C.
$20
Adamas Pharmaceuticals, Inc.
$19
EISAI INC.
$17
Celgene Corporation
$15
Catalyst Pharmaceuticals, Inc.
$15
Zogenix Inc.
$14
Top 3 companies account for 84.9% of all-time payments
Associated products mentioned in payments ›
ACTIVA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BRIUMVI · Briviact · COMIRNATY · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · HYQVIA · INGREZZA · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NURTEC ODT · Nayzilam · Neuroblate · OCREVUS · ONPATTRO · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · Ponvory · QULIPTA · QUVIVIQ · Rebif · Rystiggo · SOLIRIS · SUNOSI · Sunosi · TECFIDERA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · Wakix · XYWAV · ZEPOSIA · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
36
County median income
$97,273
Nearest hospital to ZIP centroid (approximate)
VASSAR BROTHERS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Koszer is a clinical cardiology specialist, with above-average Medicare volume (top 18% in NY), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Koszer experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Koszer performed 872 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Koszer receive payments from pharmaceutical companies?
Yes. Dr. Koszer received a total of $21,180 from 43 companies across 286 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Koszer's costs compare to other neurologists in Poughkeepsie?
Dr. Koszer's average Medicare payment per service is $110. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Koszer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Poughkeepsie
Browse neurologists in Poughkeepsie ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology